Texas and Florida have launched the latest lawsuit seeking to restrict access to the abortion pill mifepristone, following the US Food and Drug Administration’s recent approval of a new generic version.
In the lawsuit, filed late on Tuesday in federal court in Wichita Falls, Texas, the states’ Republican attorneys general argue that the FDA has failed to thoroughly evaluate the drug’s safety and effectiveness since its initial approval in 2000 and disregarded the risks to the women who take it.
